Type 1 diabetes is an autoimmune disease that occurs when your pancreas does not produce insulin. Here's what you should know ...

A 2-year follow-up of the randomized, placebo-controlled BANDIT trial shows that stopping baricitinib leads to a loss of therapeutic benefit, supporting its evaluation in earlier stages of type 1 ...

Henagliflozin, a diabetes treatment approved in China, may do more than just control blood sugar—it may actually slow ...

The U.S. government shutdown enters its third day as partisan gridlock deepens, freezing $1.7 trillion in federal spending ...